Skip to main content
SpringerLink
Log in

Somatic Problems and Dual Disorder Patients

  • Chapter
  • First Online:
Co-occurring Addictive and Psychiatric Disorders

Abstract

Individuals with severe mental illness (SMI) are prone to many different physical health problems. While these diseases are, compared with the general population, more prevalent among people with SMI, their impact on individuals with a dual disorder (=the co-occurrence of SMI with substance use disorder, SUD) seems even to be more significant. Although general research is limited, there is sufficient evidence to conclude that dual disorder patients have a significantly greater medical comorbidity than SMI patients without an SUD. This is confirmed by additional research on major medical diseases in these patients. Studies in SMI patients show a strong relationship between SUDs and human immunodeficiency virus and hepatitis C virus infection. Cigarette smoking and drug abuse, which are highly prevalent among SMI people, are implicated in a higher risk for developing respiratory tract diseases, such as chronic pulmonary disease, and cardiovascular diseases. However, although medical health problems are more prevalent in dual disorder patients, a substantial proportion of these patients do not receive any treatment for these somatic problems. Specific patient, provider, and system factors act as barriers to the recognition and the management of physical disease in these highly vulnerable patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Batki SL, Meszaros ZS, Strutynski K et al (2009) Medical comorbidity in patients with schizophrenia and alcohol dependence. Schizophr Res 107(2–3):139–146

    Article  PubMed Central  PubMed  Google Scholar 

  • Benaiges I, Prat G, Adan A (2012) Health-related quality of life in patients with dual diagnosis: clinical correlates. Health Qual Life Outcomes 10:106

    Article  PubMed Central  PubMed  Google Scholar 

  • Bonner JE, Barritt AS 4th, Fried MW et al (2012) Time to rethink antiviral treatment for hepatitis C in patients with coexisting mental health/substance abuse issues. Dig Dis Sci 57(6):1469–1474

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Buckley PF (2006) Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness. J Clin Psychiatry 67(Suppl 7):5–9

    PubMed  Google Scholar 

  • Chen YH, Lin HC, Lin HC (2011) Poor clinical outcomes among pneumonia patients with schizophrenia. Schizophr Bull 37(5):1088–1094

    Article  PubMed Central  PubMed  Google Scholar 

  • De Hert M, Detraux J, Vancampfort D et al (2012) Severe mental illness and diabetes mellitus type 2. Die Psychiatrie 9(3):159–164

    Google Scholar 

  • De Hert M, Correll CU, Bobes J et al (2011a) Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 10(1):52–77

    Google Scholar 

  • De Hert M, Trappeniers L, Wampers M et al (2011b) Knowledge about HIV in people with schizophrenia: a general population comparison. Clin Schizophr Relat Psychoses 5(2):80–86

    Article  PubMed  Google Scholar 

  • De Hert M, Cohen D, Bobes J et al (2011c) Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry 10(2):138–151

    PubMed  Google Scholar 

  • De Hert M, Detraux J, van Winkel R et al (2011d) Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol 8(2):114–126

    Article  PubMed  Google Scholar 

  • De Hert M, Katarina R, Benoit G et al (2010) Dual diagnosis among schizophrenic patients in Belgian psychiatric services: prevalence and available treatment options. Acta Psychiatr Belg 110(2):43–50

    Google Scholar 

  • De Hert M, Wampers M, Van Eyck D et al (2009a) Prevalence of HIV and hepatitis C infection among patients with schizophrenia. Schizophr Res 108(1–3):307–308

    Article  PubMed  Google Scholar 

  • De Hert M, Dekker JM, Wood D et al (2009b) Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry 24(6):412–424

    Article  PubMed  Google Scholar 

  • De Leon J, Diaz FJ (2005) A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 76(2–3):135–157

    Article  PubMed  Google Scholar 

  • Department Of Health And Human Services, Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment (2008). Drugs, alcohol and HIV/AIDS. A consumer Guide. U.S. http://www.samhsa.gov. Accessed 28 June 2013

  • Devlin RJ, Henry JA (2008) Clinical review: major consequences of illicit drug consumption. Crit Care 12(1):202

    Article  PubMed Central  PubMed  Google Scholar 

  • Dickey B, Normand SL, Weiss RD et al (2002) Medical morbidity, mental illness, and substance use disorders. Psychiatr Serv 53(7):861–867

    Article  PubMed  Google Scholar 

  • Filik R, Sipos A, Kehoe PG et al (2006) The cardiovascular and respiratory health of people with schizophrenia. Acta Psychiatr Scand 113(4):298–305

    Article  CAS  PubMed  Google Scholar 

  • Forey BA, Thornton AJ, Lee PN (2011) Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulm Med 14(11):36

    Article  Google Scholar 

  • Harris KM, Edlund MJ (2005) Use of mental health care and substance abuse treatment among adults with co-occurring disorders. Psychiatr Serv 56(8):954–959

    Article  PubMed  Google Scholar 

  • Hillbom M, Saloheimo P, Juvela S (2011) Alcohol consumption, blood pressure, and the risk of stroke. Curr Hypertens Rep 13(3):208–213

    Article  CAS  PubMed  Google Scholar 

  • Himelhoch S, Lehman A, Kreyenbuhl J et al (2004) Prevalence of chronic obstructive pulmonary disease among those with serious mental illness. Am J Psychiatry 161(12):2317–2319

    Article  PubMed  Google Scholar 

  • Himelhoch S, McCarthy JF, Ganoczy D et al (2007) Understanding associations between serious mental illness and HIV among patients in the VA health system. Psychiatr Serv 58:1165–1172

    Article  PubMed  Google Scholar 

  • Huckans MS, Blackwell AD, Harms TA et al (2006) Management of hepatitis C disease among VA patients with schizophrenia and substance use disorders. Psychiatr Serv 57(3):403–406

    Article  PubMed  Google Scholar 

  • Kelly DL, McMahon RP, Wehring HJ et al (2011) Cigarette smoking and mortality risk in people with schizophrenia. Schizophr Bull 37(4):832–838

    Article  PubMed Central  PubMed  Google Scholar 

  • Kilbourne AM, Morden NE, Austin K et al (2009) Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors. Gen Hosp Psychiatry 31(6):555–563

    Article  PubMed Central  PubMed  Google Scholar 

  • Klinkenberg WD, Caslyn RJ, Morse GA et al (2003) Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders. Compr Psychiatry 44(4):293–302

    Article  PubMed  Google Scholar 

  • Lin WC, Zhang J, Leung GY et al (2011) Chronic physical conditions in older adults with mental illness and/or substance use disorders. J Am Geriatr Soc 59(10):1913–1921

    Article  PubMed  Google Scholar 

  • Loftis JM, Matthews AM, Hauser P (2006) Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management. Drugs 66(2):155–174

    Article  PubMed  Google Scholar 

  • Matthews AM, Huckans MS, Blackwell AD et al (2008) Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders. Bipolar Disord 10(2):266–270

    Article  PubMed  Google Scholar 

  • Matusow H, Guarino H, Rosenblum A et al (2013) Consumers’ experiences in dual focus mutual aid for co-occurring substance use and mental health disorders. Subst Abuse 7:39–47

    PubMed Central  PubMed  Google Scholar 

  • Meade CS (2006) Sexual risk behavior among persons dually diagnosed with severe mental illness and substance use disorder. J Subst Abuse Treat 30(2):147–157

    Article  PubMed  Google Scholar 

  • Meade CS, Kershaw TS, Hansen NB et al (2009) Long-term correlates of childhood abuse among adults with severe mental illness: adult victimization, substance abuse, and HIV sexual risk behavior. AIDS Behav 13(2):207–216

    Article  PubMed Central  PubMed  Google Scholar 

  • Meszaros ZS, Dimmock JA, Ploutz-Snyder R et al (2011) Accuracy of self-reported medical problems in patients with alcohol dependence and co-occurring schizophrenia or schizoaffective disorder. Schizophr Res 132(2–3):190–193

    Article  PubMed Central  PubMed  Google Scholar 

  • Meyer JM (2003) Prevalence of hepatitis A, hepatitis B, and HIV among hepatitis C-seropositive state hospital patients: results from Oregon State Hospital. J Clin Psychiatry 64(5):540–545

    Article  PubMed  Google Scholar 

  • Mistler LA, Brunette MF, Marsh BJ et al (2006) Hepatitis C treatment for people with severe mental illness. Psychosomatics 47(2):93–107

    Article  CAS  PubMed  Google Scholar 

  • Prince JD, Walkup J, Akincigil A et al (2012) Serious mental illness and risk of new HIV/AIDS diagnoses: an analysis of Medicaid beneficiaries in eight states. Psychiatr Serv 63(10):1032–1038

    Article  PubMed  Google Scholar 

  • Rosenberg SD, Goodman LA, Osher FC et al (2001) Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health 91(1):31–37

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Swendsen J, Conway KP, Degenhardt L et al (2010) Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction 105(6):1117–1128

    Article  PubMed Central  PubMed  Google Scholar 

  • Tandon R, Nasrallah HA, Keshavan MS (2009) Schizophrenia, “just the facts” 4. Clinical features and conceptualization. Schizophr Res 110(1–3):1–23

    Article  PubMed  Google Scholar 

  • Testa A, Giannuzzi R, Sollazzo F et al (2013) Psychiatric emergencies (part II): psychiatric disorders coexisting with organic diseases. Eur Rev Med Pharmacol Sci 17(Suppl 1):65–85

    PubMed  Google Scholar 

  • U.S. Department of health and human services. Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality. Results from the 2010 National Survey on Drug Use and Health: Mental Health Findings. http://www.samhsa.gov/data/nsduh/2k10MH_Findings/2k10MHResults.pdf. Accessed 28 June 2013

  • Vergara-Rodriguez P, Vibhakar S, Watts J (2009) Metabolic syndrome and associated cardiovascular risk factors in the treatment of persons with human immunodeficiency virus and severe mental illness. Pharmacol Ther 124:269–278

    Article  CAS  PubMed  Google Scholar 

  • Welsh C, Goldberg R, Tapscott S et al (2012) “Shotgunning” in a population of patients with severe mental illness and comorbid substance use disorders. Am J Addict 21(2):120–125

    Article  PubMed  Google Scholar 

  • Ziedonis DM, Smelson D, Rosenthal RN et al (2005) Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. J Psychiatr Pract 11(5):315–339

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosciences, KU Leuven, Kortenberg, Belgium

    Marc De Hert

  2. University Psychiatric Centre, KU Leuven, Kortenberg, Belgium

    Davy Vancampfort & Johan Detraux

Authors
  1. Marc De Hert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Davy Vancampfort
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Johan Detraux
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marc De Hert .

Editor information

Editors and Affiliations

  1. Collaborative Psychiatric Research Institute, Antwerp University PC Alexian Brothers Boechout, Boechout, Belgium

    Geert Dom

  2. Clinical Psychological Service and Department, University Hospital of Psychiatry & University of Bern, Bern, Switzerland

    Franz Moggi

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

De Hert, M., Vancampfort, D., Detraux, J. (2015). Somatic Problems and Dual Disorder Patients. In: Dom, G., Moggi, F. (eds) Co-occurring Addictive and Psychiatric Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-45375-5_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-45375-5_23

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-45374-8

  • Online ISBN: 978-3-642-45375-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation